EC
EcoR1 Capital’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2M | Sell |
500,000
-57,576
| -10% | -$1.64M | 0.84% | 23 |
|
|
2025
Q1 | $16.5M | Hold |
557,576
| – | – | 0.98% | 19 |
|
|
2024
Q4 | $16.2M | Sell |
557,576
-200,000
| -26% | -$5.82M | 0.61% | 29 |
|
|
2024
Q3 | $34.8M | Hold |
757,576
| – | – | 1.19% | 22 |
|
|
2024
Q2 | $30.9M | Hold |
757,576
| – | – | 0.95% | 24 |
|
|
2024
Q1 | $19.3M | Buy |
+757,576
| New | +$19.3M | 0.49% | 37 |
|
|
2022
Q4 | – | Sell |
-2,899,285
| Closed | -$47.3M | – | 71 |
|
|
2022
Q3 | $47.3M | Buy |
2,899,285
+139,780
| +5% | +$2.28M | 1.4% | 17 |
|
|
2022
Q2 | $40.1M | Hold |
2,759,505
| – | – | 1.38% | 23 |
|
|
2022
Q1 | $51M | Hold |
2,759,505
| – | – | 1.59% | 19 |
|
|
2021
Q4 | $65.6M | Hold |
2,759,505
| – | – | 2.09% | 14 |
|
|
2021
Q3 | $68M | Buy |
2,759,505
+655,555
| +31% | +$16.1M | 2.36% | 13 |
|
|
2021
Q2 | $52M | Hold |
2,103,950
| – | – | 1.94% | 15 |
|
|
2021
Q1 | $45.9M | Hold |
2,103,950
| – | – | 2.04% | 15 |
|
|
2020
Q4 | $53.7M | Hold |
2,103,950
| – | – | 2.89% | 13 |
|
|
2020
Q3 | $59.2M | Hold |
2,103,950
| – | – | 4.22% | 8 |
|
|
2020
Q2 | $59.5M | Buy |
+2,103,950
| New | +$59.5M | 4.39% | 9 |
|